-
Sponsored by Patrinos & KilimirisYouli Angelou of Patrinos & Kilimiris explains why the consolidation of all branches of industrial property is a welcome move
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S discusses a technical board of appeal referral that deals with the issue of entitlement to priority
-
Sponsored by Remfry & SagarShukadev Khuraijam and Ankush Verma of Remfry & Sagar discuss pre-grant straw man oppositions in India and the impact of a recent decision of the Bombay High Court
-
Sponsored by LexOrbisManisha Singh and Pradeep Kumar Kamal of LexOrbis explain how India has adopted a unique solution to protecting the rights of plant breeders and farmers
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners analyses the One-Blue case where patentees made a FRAND declaration for SEPS
-
Sponsored by AJ ParkAJ Park explains what businesses should be aware of when purchasing an NFT
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law discusses a recent case in which the Fishcake Restaurant trademark was invalidated because the owner sold sausage stew, rather than fishcakes
-
Sponsored by Bird & BirdEmma Green of Bird & Bird explores four important areas for brand owners to consider when looking at the realms of the metaverse
-
Sponsored by RNA, Technology and IP AttorneysVirtual digital assets, including crypto and NFTs, are on the rise in India. Ranjan Narula, Abhishek Nangia and Daleep Kumar of RNA Technology and IP Attorneys examine the new ASCI guidelines regulating their advertising
-
Sponsored by Cabinet Beau de LoméniePatent experts from Beau de Loménie discuss the Unitary Patent Court and actions to be taken before its implementation
-
Sponsored by Maiwald Intellectual PropertyMatthias Hoffmann of Maiwald discusses the uncertainty over the transfer of priority rights and the joint applicants approach at the EPO
-
Sponsored by Gün and PartnersAysel Korkmaz Yatkın and Fatma Sevde Tan of Gün and Partners discuss a welcome decision that reinforces patent owners’ right to information about pharmaceutical licensing applications in Turkey